Rybelsus Prices, Coupons, Copay Cards & Patient Assistance
Rybelsus (semaglutide) is a member of the GLP-1 Agonists (Incretin Mimetics) drug class and is commonly used for Type 2 Diabetes.
The cost for Rybelsus 1.5 mg oral tablet is around $1,075 for a supply of 30 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Rybelsus is available as a brand name drug only, a generic version is not yet available. View generic Rybelsus availability for more details.
Rybelsus prices
Oral Tablet
1.5 mg
Rybelsus oral tablet
from $1,074.94
for 30 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 30 | $35.83 | $1,074.94 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
3 mg
Rybelsus oral tablet
from $1,074.94
for 30 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 30 | $35.83 | $1,074.94 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
4 mg
Rybelsus oral tablet
from $1,074.94
for 30 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 30 | $35.83 | $1,074.94 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
7 mg
Rybelsus oral tablet
from $1,074.94
for 30 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 30 | $35.83 | $1,074.94 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
9 mg
Rybelsus oral tablet
from $1,074.94
for 30 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 30 | $35.83 | $1,074.94 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
14 mg
Rybelsus oral tablet
from $1,074.94
for 30 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 30 | $35.83 | $1,074.94 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Rybelsus Coupons, Copay Cards and Rebates
Rybelsus offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Rybelsus Savings Card
Eligible commercially insured patients may pay as little as $10 per 30-day prescription with a maximum savings of $300 per fill.
- Applies to:
- Rybelsus
- Number of uses:
- 24 times
Form more information phone: 877-304-6855 or Visit website
Healthcare providers may submit a sample request through the Novo Nordisk Sample Portal for Rybelsus; sample requests may be submitted every 30 days.
- Applies to:
- Rybelsus
- Number of uses:
- Once per month until program expires
Form more information phone: 877-304-6855 or Visit website
Rybelsus Savings Card
Eligible commercially insured patients may submit a rebate request if using a mail-order pharmacy or a retail pharmacy that does not accept the Saving Card.
- Applies to:
- Rybelsus
- Number of uses:
- One rebate per prescription fill
Form more information phone: 877-304-6855 or Visit website
Patient Assistance & Copay Programs for Rybelsus
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: HealthWell Foundation Copay Program
Eligibility requirements:- May have insurance
- Varies
- FDA Approved Diagnosis - See Program Website for Details
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
- Rybelsus (semaglutide) Tablet
More information please phone: 800-675-8416 Visit Website
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Rybelsus (semaglutide) Tablet
More information please phone: 866-316-7263 Visit Website
Provider: Novo Nordisk Patient Assistance Program
Eligibility requirements:- Must be uninsured
- At or below 400% of FPL
- Not specified
- The patient must be a US citizen or legal resident.
- This program also provides copay assistance. *Medicare Part D enrollment deadline is November 30 of each year.
- Rybelsus (semaglutide) Tablet
More information please phone: 866-310-7549 or 844-668-6463 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Trulicity
Trulicity is an injectable diabetes medicine that is used together with diet and exercise to ...
Lantus
Lantus is a long acting form of insulin used to treat type 1 or type 2 diabetes. Learn about side ...
Mounjaro
Mounjaro (tirzepatide) is FDA-approved to manage type 2 diabetes in adults. It lowers blood sugar ...
Tresiba
Tresiba (insulin degludec) is used to treat diabetes mellitus. Includes Tresiba side effects ...
Victoza
Victoza helps control blood sugar levels and reduce the risk of serious heart problems in people ...
Basaglar
Basaglar (insulin glargine) is a long-acting insulin that is used to improve blood sugar control in ...
Levemir
Levemir (insulin detemir) is a long acting insulin used to treat diabetes in adults and children ...
Novolog
NovoLog is a fast-acting insulin used to treat diabetes to control blood sugar levels in adults and ...
Soliqua
Soliqua 100/33 (insulin glargine and lixisenatide) is used to treat type 2 diabetes. Includes ...
Toujeo SoloStar
Toujeo (insulin glargine) is an injection used to treat type 1 or type 2 diabetes. Includes Toujeo ...
More about Rybelsus (semaglutide)
- Check interactions
- Compare alternatives
- Reviews (290)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: GLP-1 Agonists (Incretin Mimetics)
- Breastfeeding
- En español
